CBD (Cannabidiol): What It Is, What Research Shows and Safety
What CBD is, the one approved CBD medicine, what research shows for anxiety, pain and sleep, and the liver, interaction, pregnancy and product-quality concerns.
Content last updated . This page has not been medically reviewed.
Overview and classification
CBD (cannabidiol) is a compound found in the cannabis plant. It is marketed in supplements, foods, oils and lotions. Unlike THC, it is not intoxicating, but it can cause side effects such as drowsiness, decreased appetite, vomiting and diarrhea. [1] The FDA says CBD is a single compound, while marijuana is a plant that contains many compounds, including CBD and THC. [2]A 2018 WHO expert review found no evidence of abuse or dependence potential for CBD in humans and described it as generally well tolerated. It noted that adverse effects may come from interactions with a person's existing medicines. [3] In a 2020 consumer update, the FDA says the limited safety data it has seen point to real risks, covered below. [2]
Evidence labels used on this page: approved medicine, promising but limited, mixed, insufficient evidence, preclinical (cells/animals only) and marketing claim.
Where it comes from
CBD is a natural cannabinoid formed from its acid precursor, CBDA, by decarboxylation, and it can also be made synthetically. [3] In US federal law, hemp is cannabis with no more than 0.3 percent delta-9 THC on a dry weight basis. [4] The FDA says that even after the 2018 Farm Bill removed hemp from the definition of marijuana, CBD products are still subject to the same laws as other FDA-regulated products. [2] For chemistry see cannabis chemistry.Regulatory category (as read from regulators)
| Where | What the regulator says |
|---|---|
| United States (FDA) | One CBD medicine is approved: a prescription product for seizures linked to Lennox-Gastaut syndrome, Dravet syndrome or tuberous sclerosis complex in people 1 year and older. [4] The FDA says it is currently illegal to market CBD by adding it to a food or labeling it as a dietary supplement. [2] |
| United States (states) | Whether products can be sold within a state depends on that state's laws. [5] |
| European Union (EMA) | Epidyolex is authorized as an add-on to clobazam for Lennox-Gastaut or Dravet syndrome from age 2, and with other epilepsy treatments for tuberous sclerosis complex from age 2. [6] |
| Other countries | Not verified here. See cannabis and CBD laws. Laws change and this is not legal advice. |
What research shows, by use
| Use | Label | What the sources say |
|---|---|---|
| Seizures in Lennox-Gastaut, Dravet, tuberous sclerosis | approved medicine | The EMA reports five studies in over 900 patients. In two Lennox-Gastaut studies, drop seizures fell by up to 64 percent with the medicine plus clobazam versus up to 31 percent with placebo plus clobazam. [6] |
| Other forms of epilepsy | insufficient evidence | NCCIH says not enough research has been done on other, more common forms to reach conclusions. [5] |
| Anxiety | mixed / promising but limited | One study of 24 people with social anxiety found less anxiety in a simulated speaking test after CBD than placebo. [5] A 2024 review of 11 randomized trials found contradictory results overall, with CBD possibly reducing anxiety versus placebo; it called for better trials. [7] |
| Chronic pain | insufficient evidence for CBD alone | The pain reviews NCCIH describes covered cannabis and cannabinoids as a group and found a small benefit that may be too small to matter to patients. [5] |
| Sleep | insufficient evidence | A 2024 review of 21 recent studies said the evidence does not match the widespread use of cannabinoids for sleep disorders. [8] |
| Cancer, Alzheimer's disease, psychiatric disorders, diabetes | marketing claim | The FDA has warned companies to stop selling CBD products claimed to prevent or treat serious diseases such as these. [2] |
See also cannabis for pain and sleep and neurological conditions research.
Risks, adverse effects and interactions
- Liver injury. The FDA says CBD can cause liver injury. [2] The prescription label requires liver tests before starting and warns that the risk is higher with valproate. [9]
- Other medicines. The FDA says CBD can affect how other drugs work, potentially causing serious side effects. [2] See how interactions work and CBD and cannabis interactions.
- Sedation. Using CBD with alcohol or other drugs that slow brain activity increases the risk of sedation and drowsiness, which can lead to injuries. [2]
- Mood and appetite. The FDA also lists diarrhea or decreased appetite, and irritability or agitation; these should improve when CBD is stopped or reduced. [2]
- Numbers from the approved medicine. In controlled studies of the prescription product, 32 percent of treated patients had somnolence or sedation versus 11 percent on placebo, and 46 percent of treated patients who were also taking clobazam. [9] These figures apply to that medicine under medical supervision, not to store products.
- Animal findings. The FDA notes male reproductive toxicity in animal studies; whether this happens in humans is not known. [2]
- Does CBD turn into THC? The WHO review found no evidence that oral CBD converts to THC in humans. [3]
- What is unknown. The FDA lists unanswered questions, including daily long-term use, which amounts trigger known risks, how consumption methods differ, and effects on the developing brain. [2]
Special groups
- Pregnancy and breastfeeding. The FDA lists effects on the developing fetus or breastfed newborn as unknown. [2] The prescription label says animal data suggest it may cause fetal harm, and that there are no data on human milk. [9] See pregnancy and breastfeeding.
- Children. The FDA lists effects on the developing brain as unknown. [2] The prescription medicine is approved from age 1 for the seizure disorders above. [9]
- Liver disease. The label recommends dosage adjustment in moderate or severe hepatic impairment. [9] See liver safety.
- Mood. The label tells prescribers to monitor for new or worsening depression and suicidal thoughts with this class of medicine. [9]
Quality and labeling concerns
The FDA tested the chemical content of some products and found many did not contain the CBD level claimed; it is also investigating reports of unsafe levels of contaminants such as pesticides, heavy metals and THC. [2] NIDA reports that some products marketed as CBD contain THC. [1] See product forms and labels and certificates of analysis.Related guides
CBD vs THC and approved cannabinoid medicines.Frequently asked questions
Is CBD the same as marijuana?
No. The FDA says CBD is a single compound, while marijuana is a plant material containing many compounds, including CBD and THC. [2]
Will CBD get me high?
CBD is not intoxicating like THC. [1] But some products sold as CBD have been found to contain THC. [1]
Is CBD legal?
In the US, hemp with no more than 0.3 percent THC is not a controlled substance, but the FDA says adding CBD to food or selling it as a dietary supplement is illegal, and state laws vary. [4][2][5] Other countries differ. Laws change and this is not legal advice.
Does CBD help anxiety or sleep?
Evidence is limited and mixed for anxiety, and insufficient for sleep. [7][8]
Can CBD interact with my medicines?
Yes. The FDA says CBD can affect how other drugs work. [2] Talk with your prescriber or pharmacist; see talking with a health professional.
What should I do if a child eats a CBD or cannabis product?
The FDA says to take the child to a physician or emergency department if you reasonably suspect accidental ingestion, especially if the child acts unusually or feels sick. [4] In the US, Poison Help is 1-800-222-1222.
References
- National Institute on Drug Abuse (NIDA). Cannabis (Marijuana) DrugFacts. Read 2026-10-22.
- US Food and Drug Administration. What You Need to Know (And What We're Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD. FDA page states content current as of 03/05/2020. Read 2026-10-22.
- World Health Organization, Expert Committee on Drug Dependence, 40th meeting. Cannabidiol (CBD) Critical Review Report. June 2018. Read 2026-10-22.
- US Food and Drug Administration. FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD): Questions and Answers. Read 2026-10-22.
- National Center for Complementary and Integrative Health (NCCIH). Cannabis (Marijuana) and Cannabinoids: What You Need To Know. Read 2026-10-22.
- European Medicines Agency. Epidyolex: EPAR medicine overview. Read 2026-10-22.
- Coelho et al. The Impact of Cannabidiol Treatment on Anxiety Disorders: A Systematic Review of Randomized Controlled Clinical Trials. Life (Basel, Switzerland). 2024. PubMed abstract read 2026-10-22.
- Lavender et al. Using Cannabis and CBD to Sleep: An Updated Review. Current psychiatry reports. 2024. PubMed abstract read 2026-10-22.
- US National Library of Medicine, DailyMed. EPIDIOLEX (cannabidiol) solution, prescribing information. Label version listed as published June 15, 2026. Read 2026-10-22.